Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

FDA clears Oryzon’s phase 1/2 trial for lung cancer treatment

April 10, 2024 Research and Development FDA, Oncology, Oryzon, lung cancer

Oryzon Genomics has announced that the US Food and Drug Administration (FDA) has approved its investigational new drug (IND) application …
News

Geneos Therapeutics shares data from phase 1/2 trial for cancer vaccine

April 8, 2024 Research and Development Cancer, Geneos Therapeutics, Oncology, clinical trial

Geneos Therapeutics has announced that it has published positive safety, immunogenicity and efficacy data from the full cohort of patients …
News

AstraZeneca shares results for Imfinzi in phase 3 trial for small cell lung cancer

April 5, 2024 Research and Development AstraZeneca, Imfinzi, Oncology, clinical trial, lung cancer

AstraZeneca has announced positive high-level results from the phase 3 ADRIATIC trial, which demonstrated that Imfinzi (durvalumab) had a statistically …
News

EnteroBiotix begins phase 2 trial of IBS treatment

April 3, 2024 Research and Development EnteroBiotix, Gastrointestinal tract, IBS, irritable bowel syndrome

EnteroBiotix has announced that it has dosed the first patient in its multi-centre, randomised, double-blind, placebo controlled clinical trial, which …
News

FDA accepts BLA for AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan for breast cancer treatment

April 2, 2024 Research and Development AstraZeneca, Daiichi Sankyo, FDA, Oncology, bla, breast cancer

AstraZeneca and Daiichi Sankyo have announced that their Biologics License Application (BLA) for datopotamab deruxtecan (Dato-Dxd) has been accepted in …
News

Heidelberg Pharma gains FDA ODD for ATAC candidate

March 27, 2024 Research and Development FDA, Oncology, heidelberg pharma, multiple myeloma

Heidelberg Pharma has announced that it has gained Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA) …
News

Curve Therapeutics’ CSO publishes research on HIF inhibition for cancer treatment

March 26, 2024 Research and Development Cancer, Curve Therapeutics, HIF inhibition, Oncology, oncology

Curve Therapeutics has announced that its chief scientific officer, Professor Ali Tavassoli has published research in the Journal of the …
News

Sosei Heptares doses first patient in trial for inflammatory bowel disease treatment

March 21, 2024 Research and Development Gastrointestinal tract, Sosei Heptares, clinical trial, inflammatory bowel disease, phase 1 trial

Sosei Heptares has announced that it has dosed the first patient in its phase 1 trial assessing a novel EP4 …
News

J&J MedTech to work with NVIDIA for surgical AI

March 19, 2024 Research and Development Johnson & Johnson MedTech, NVIDIA, Pharmacy, surgery, surgical AI

Johnson & Johnson (J&J) MedTech has announced that it is working in collaboration with NVIDIA to accelerate and scale artificial …
News

GSK shares data from phase 3 trial for Jemperli combinations for endometrial cancer treatment

March 18, 2024 Research and Development GSK, Jemperli, Oncology, clinical trial, endometrial cancer, women's health

GSK has announced positive results from part 1 and part 2 of its RUBY/ENGOT-EN6/GOG3031/NSGO phase 3 trial for Jemperli (dostarlimab) …
News

Merck shares results for Keytruda in cervical cancer treatment

March 18, 2024 Research and Development Merck, Oncology, cervical cancer, keytruda, women's health

Merck, known as MSD outside of the US and Canada, has announced positive results from the phase 3 KEYNOTE-A18 trial, …
News

Allumiqs and Prolytix enter partnership for acceleration of drug discovery and development

March 15, 2024 Research and Development Allumiqs, Pharmacy, drug discovery, partnership

Allumiqs and Prolytix have announced that they have entered into a long-term, strategic partnership with the aim of providing collaboratinve …
News

Bayer and Aignostics to collaborate for AI oncology research

March 14, 2024 Research and Development AI, Bayer, Oncology, research

Bayer and Aignostics have announced that they have entered into a strategic collaboration for several artificial intelligence (AI)-powered approaches for …
News

EC approves Pfizer’s Prevenar 20 to protect paediatric patients against pneumococcal disease

March 13, 2024 Research and Development EC, EMA, Infections and infestations, Prevnar 20, pneumococcal disease

Pfizer has announced that the European Commission (EC) has granted marketing authorisation for Prevenar 20, the company’s 20-valent pneumococcal conjugate …
News

Merck plans to conduct trials for HPV vaccines

March 13, 2024 Research and Development Immunology, Merck, vaccines

Merck, known as MSD outside of the US and Canada, has announced that it is planning to initiate clinical development …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026